Google+ Facebook Twitter Twitter

Study advances field of precision medicine

A new method of quickly mapping the genome of single cells, while also clarifying the spatial position of the cells within the body, has been revealed.

The discovery represents another milestone in the field of precision medicine, it is claimed.

“It gives us a lot more precision,” said senior author Andrew Adey. 

“The single-cell aspect gives us the ability to track the molecular changes within each cell type. Our new study also allows the capture of where those cells were positioned within complex tissues, as opposed to a slurry of cells from the entire sample.”

Scientists applied a method of indexing large numbers of single cells in hundreds of microbiopsies taken from a portion of the brain in mice and from human brain tissue kept in the Oregon Health and Science University Brain Bank.

Researchers isolated tiny pieces in cross sections of tissues and used an existing technique of single-cell profiling to find differences in the epigenetic profiles of the cells with respect to their position in the tissue.

The technique could be especially useful where it’s necessary to precisely identify and target cells from specific structures within a tissue, such as cancer, or in cases of stroke, which the authors explored in the study.

Image Credit: iStock

Related Articles

Diagnose crohn’s with an engineered organism

Researchers have engineered a bacterium with the necessary capabilities for diagnosing a human disease.

Genomic medicine: Coming to the clinic near you?

Dr Rameen Shakur takes a look at how biomedical science and genomics are playing a part in real-world clinical cardiology.

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.